Advertisement
News
Advertisement

Medco and Celesio Announce Pan-European Joint Venture to Enhance Quality of Clinical Care and Reduce Overall Healthcare Costs

Mon, 06/21/2010 - 1:34am
Bio-Medicine.Org

BERLIN, June 21 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS) and Celesio AG, two of the world's leading pharmacy-driven healthcare companies, today announced a joint venture with a long-term goal of improving patient health and helping to relieve the crushing financial burden on healthcare payors across Europe.

(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20100609/MEDCOLOGO )

Headquartered in Amsterdam, the 50/50 joint venture, Medco Celesio B.V., combines Medco and Celesio's strengths in pharmacy-driven clinical care.  Medco Celesio B.V. will target patients with chronic or complex conditions, such as diabetes, asthma, high-cholesterol and heart disease.  It will concentrate on innovative, integrated clinical services designed to improve patient adherence, integrate care across multiple providers, enhance safety and deliver greater value across the healthcare system.

"Our portfolio of proven clinical solutions can be customized to address the growing demand for affordable, high-quality care that is relevant across geogra

'/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading